And as discrepancies between its eventual offerings and earlier promises became clearer, the company
began narrowing its pursuits to more successful areas.
How tactfully phrased!
Nevertheless, the Watson name went unmentioned in IBM’s latest earnings presentations for the
second quarter. The company did point to revenue growth in its cognitive software division but said it
was driven largely by its cybersecurity and cloud-based applications.
Yes, curious that there was not one peep about the vaunted and mighty Watson, curious indeed. . .
https://www.fiercebiotech.com/medtech/ibm-watson-health-s-new-manager-talks-about-returning-to-basics-and-doubling-down